Konstantinos Melas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Konstantinos Melas has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Monique M. B. Breteler
Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
8 shared publications - Nasir Ahmad Aziz
Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
7 shared publications - Mohammed Aslam Imtiaz
Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
4 shared publications - Santiago Estrada
Population Health Sciences German Centre for Neurodegenerative Diseases (DZNE) Bonn Germany
4 shared publications Valentina Talevi
Population Health Sciences, German Centre for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany
4 shared publications- Valentina Talevi
Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE)
3 shared publications
Latest Publications
- Open Access
- 11 May 2026
- Published by Elsevier in EBioMedicine
- Vol. 128, 106289
DNA methylation signatures of bilateral hippocampal volume, asymmetry and atrophy: a cross-omics analysis in the general population
- 11 May 2026
- Published by Elsevier in EBioMedicine
- Vol. 128, 106289
Open AccessDNA methylation signatures of bilateral hippocampal volume, asymmetry and atrophy: a cross-omics analysis in the general population
- Open Access
- 2 March 2026
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (8) , 809-819
Olfactory Bulb Volume Reflects Olfactory Dysfunction and Network Organization: Insights From the Population‐Based Rhineland Study
Background: Olfactory dysfunction is common in aging and an early symptom of neurodegenerative diseases, but how structural (olfactory bulb [OB] volume) and functional (olfactory network [OFN] functional connectivity [FC]) brain features interact to shape odor identification ability remains unclear. Therefore, we assessed the interrelations among OB volume, OFN FC, and odor identification ability in a large population‐based cohort. Methods: Using cross‐sectional data from 5605 participants of the Rhineland Study (age range: 30–95 years), we extracted OB volume and OFN FC from 3T MRI scans. Odor identification was examined with the 12‐item “Sniffin’ Sticks” test. Using linear regression, we examined the relations between OB volume, OFN FC, and odor identification. Results: A smaller OB was associated with worse odor identification (standardized β = 0.09, 95% confidence interval: 0.06–0.12). This association was stronger in men and strongest in older individuals of both sexes. Only in participants with a large OB, lower OFN FC was significantly associated with worse odor identification (standardized β between 0.03 and 0.12), especially among older participants (62–95 years) and in memory‐related regions (hippocampus, amygdala, and orbitofrontal cortex). Conclusion: Our findings demonstrate the importance of OB volume in detecting olfactory dysfunction. Moreover, they reveal that the OB contributes to odor identification both directly and by modulating central network function, offering new insights into olfactory dysfunction as a potential biomarker for neurodegeneration.
- 2 March 2026
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (8) , 809-819
Open AccessOlfactory Bulb Volume Reflects Olfactory Dysfunction and Network Organization: Insights From the Population‐Based Rhineland Study
Background: Olfactory dysfunction is common in aging and an early symptom of neurodegenerative diseases, but how structural (olfactory bulb [OB] volume) and functional (olfactory network [OFN] functional connectivity [FC]) brain features interact to shape odor identification ability remains unclear. Therefore, we assessed the interrelations among OB volume, OFN FC, and odor identification ability in a large population‐based cohort. Methods: Using cross‐sectional data from 5605 participants of the Rhineland Study (age range: 30–95 years), we extracted OB volume and OFN FC from 3T MRI scans. Odor identification was examined with the 12‐item “Sniffin’ Sticks” test. Using linear regression, we examined the relations between OB volume, OFN FC, and odor identification. Results: A smaller OB was associated with worse odor identification (standardized β = 0.09, 95% confidence interval: 0.06–0.12). This association was stronger in men and strongest in older individuals of both sexes. Only in participants with a large OB, lower OFN FC was significantly associated with worse odor identification (standardized β between 0.03 and 0.12), especially among older participants (62–95 years) and in memory‐related regions (hippocampus, amygdala, and orbitofrontal cortex). Conclusion: Our findings demonstrate the importance of OB volume in detecting olfactory dysfunction. Moreover, they reveal that the OB contributes to odor identification both directly and by modulating central network function, offering new insights into olfactory dysfunction as a potential biomarker for neurodegeneration.
- Open Access
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Genome-wide association meta-analysis of human olfactory identification discovers sex-specific and sex-differential genetic variants
Smelling is a human sense, expressing strong sexual dimorphisms. We aim to improve the knowledge of the genetics of human olfactory perception by performing an exploratory genome-wide association meta-analysis of up to 21,495 individuals of European ancestry. By sex-stratified and overall analysis of the identification of twelve odours and an identification score, we discovered ten independent loci, seven of them novel, with trait-wise genome-wide significance (p < 5 × 10−8) involving five odours. Seven of these loci, including four novel ones, are also significant using a stricter study-wide significance threshold (p < 3.85 × 10− 9). Loci were predominantly located within clusters of olfactory receptors. Two loci were female-specific while one was sex-differential with respective candidate genes containing androgen response elements. Two-sample Mendelian randomization was applied to search for causal relationships between sex hormones, odour identification and neurodegenerative diseases. A causal negative effect was detected for Alzheimer’s disease on the identification score. These findings deepen our understanding of the genetic basis of olfactory perception and its interaction with sex, prioritizing mechanisms for further molecular research.
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open AccessGenome-wide association meta-analysis of human olfactory identification discovers sex-specific and sex-differential genetic variants
Smelling is a human sense, expressing strong sexual dimorphisms. We aim to improve the knowledge of the genetics of human olfactory perception by performing an exploratory genome-wide association meta-analysis of up to 21,495 individuals of European ancestry. By sex-stratified and overall analysis of the identification of twelve odours and an identification score, we discovered ten independent loci, seven of them novel, with trait-wise genome-wide significance (p < 5 × 10−8) involving five odours. Seven of these loci, including four novel ones, are also significant using a stricter study-wide significance threshold (p < 3.85 × 10− 9). Loci were predominantly located within clusters of olfactory receptors. Two loci were female-specific while one was sex-differential with respective candidate genes containing androgen response elements. Two-sample Mendelian randomization was applied to search for causal relationships between sex hormones, odour identification and neurodegenerative diseases. A causal negative effect was detected for Alzheimer’s disease on the identification score. These findings deepen our understanding of the genetic basis of olfactory perception and its interaction with sex, prioritizing mechanisms for further molecular research.
- Open Access
Blood-derived microRNA signatures associated with hippocampal structure and atrophy rate: Findings from the Rhineland Study
MicroRNAs have been linked to brain disorders, but their relations with hippocampal structure and atrophy remain unexplored. As the hippocampus is pivotal for cognition and dementia, understanding these relations and their specificity for the hippocampus would elucidate microRNA involvement in brain health and neurodegeneration. Here, using population-based data, we cross-sectionally and longitudinally examined the associations of blood-derived microRNAs with left and right hippocampal volume, hippocampal asymmetry, and total brain volume. Expression of microRNAs and their putative target genes was measured at study baseline in whole blood using RNA sequencing. Brain imaging measures were examined at baseline and re-examined 4.60 to 8.02 years later using 3T MRI. We investigated microRNA associations with imaging measures cross-sectionally using linear regression and longitudinally using linear mixed-effect models. Cross-sectionally, six microRNAs (miR-199a-3p, miR-199b-3p, miR-155-5p, miR-146a-5p, miR-6859-5p, miR-505-5p) were associated exclusively with left hippocampal volume. Longitudinally, another five microRNAs (miR-361-3p, miR-4473, miR-381-3p, miR-543, miR-370-3p) were associated with left hippocampal, right hippocampal, and total brain atrophy rates. Twenty-one microRNAs were exclusively associated with total brain atrophy rate. MicroRNAs identified in the cross-sectional analysis regulated target genes involved in brain development, memory, and synapse assembly. MicroRNAs from the longitudinal analysis regulated genes related to axonal and dendritic growth. Our findings suggest an asymmetric and specialized role of the cross-sectional microRNA signature during left hippocampal early-life development and a more universal role of the longitudinal signature during whole-brain aging or neurodegeneration. Importantly, some identified microRNAs have been previously linked to dementia and could be investigated as presymptomatic blood-based biomarkers.
Open AccessBlood-derived microRNA signatures associated with hippocampal structure and atrophy rate: Findings from the Rhineland Study
MicroRNAs have been linked to brain disorders, but their relations with hippocampal structure and atrophy remain unexplored. As the hippocampus is pivotal for cognition and dementia, understanding these relations and their specificity for the hippocampus would elucidate microRNA involvement in brain health and neurodegeneration. Here, using population-based data, we cross-sectionally and longitudinally examined the associations of blood-derived microRNAs with left and right hippocampal volume, hippocampal asymmetry, and total brain volume. Expression of microRNAs and their putative target genes was measured at study baseline in whole blood using RNA sequencing. Brain imaging measures were examined at baseline and re-examined 4.60 to 8.02 years later using 3T MRI. We investigated microRNA associations with imaging measures cross-sectionally using linear regression and longitudinally using linear mixed-effect models. Cross-sectionally, six microRNAs (miR-199a-3p, miR-199b-3p, miR-155-5p, miR-146a-5p, miR-6859-5p, miR-505-5p) were associated exclusively with left hippocampal volume. Longitudinally, another five microRNAs (miR-361-3p, miR-4473, miR-381-3p, miR-543, miR-370-3p) were associated with left hippocampal, right hippocampal, and total brain atrophy rates. Twenty-one microRNAs were exclusively associated with total brain atrophy rate. MicroRNAs identified in the cross-sectional analysis regulated target genes involved in brain development, memory, and synapse assembly. MicroRNAs from the longitudinal analysis regulated genes related to axonal and dendritic growth. Our findings suggest an asymmetric and specialized role of the cross-sectional microRNA signature during left hippocampal early-life development and a more universal role of the longitudinal signature during whole-brain aging or neurodegeneration. Importantly, some identified microRNAs have been previously linked to dementia and could be investigated as presymptomatic blood-based biomarkers.
- Open Access
Integrative cross-omics analysis identifies DNA methylation signatures associated with bilateral hippocampal volume, asymmetry and atrophy rate in the general population
The hippocampus exhibits volumetric differences between the left and right hemispheres (LHCV and RHCV) and asymmetry, yet the molecular mechanisms underlying these features remain unclear. In this study, we performed a meta-analysis of epigenome-wide association studies (EWAS) across six population-based cohorts (n=8,156; 53% women; mean age: 60.7 years) to identify blood-based methylation signatures associated with LHCV, RHCV, and hippocampal asymmetry. Integrative cross-omics analyses using individual-level genetic, methylation, and gene expression data (n > 2,624 participants from the Rhineland Study) revealed 15 CpG/DMR-gene expression pairs linked to LHCV and 18 pairs to RHCV, implicating pathways involved in neuronal differentiation and immune processes. Notably, baseline methylation at these loci predicted bilateral hippocampal atrophy rates, explaining over 10% of the variation. Four CpGs were consistently associated with hippocampal asymmetry cross-sectionally and longitudinally, exhibiting sex-specific differences. Additionally, adherence to healthy dietary patterns was associated with these methylation signatures, highlighting modifiable influences on hippocampal health and atrophy.
Open AccessIntegrative cross-omics analysis identifies DNA methylation signatures associated with bilateral hippocampal volume, asymmetry and atrophy rate in the general population
The hippocampus exhibits volumetric differences between the left and right hemispheres (LHCV and RHCV) and asymmetry, yet the molecular mechanisms underlying these features remain unclear. In this study, we performed a meta-analysis of epigenome-wide association studies (EWAS) across six population-based cohorts (n=8,156; 53% women; mean age: 60.7 years) to identify blood-based methylation signatures associated with LHCV, RHCV, and hippocampal asymmetry. Integrative cross-omics analyses using individual-level genetic, methylation, and gene expression data (n > 2,624 participants from the Rhineland Study) revealed 15 CpG/DMR-gene expression pairs linked to LHCV and 18 pairs to RHCV, implicating pathways involved in neuronal differentiation and immune processes. Notably, baseline methylation at these loci predicted bilateral hippocampal atrophy rates, explaining over 10% of the variation. Four CpGs were consistently associated with hippocampal asymmetry cross-sectionally and longitudinally, exhibiting sex-specific differences. Additionally, adherence to healthy dietary patterns was associated with these methylation signatures, highlighting modifiable influences on hippocampal health and atrophy.
- Open Access
- 29 August 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (10) , 7138-7159
Blood‐derived microRNAs are related to cognitive domains in the general population
INTRODUCTION: Blood‐derived microRNAs (miRNAs) are potential candidates for detecting and preventing subclinical cognitive dysfunction. However, replication of previous findings and identification of novel miRNAs associated with cognitive domains, including their relation to brain structure and the pathways they regulate, are still lacking.METHODS: We examined blood‐derived miRNAs and miRNA co‐expression clusters in relation to cognitive domains, structural magnetic resonance imaging measures, target gene expression, and genetic variants in 2869 participants of a population‐based cohort.RESULTS: Five previously identified and 14 novel miRNAs were associated with cognitive domains. Eleven of these were also associated with cortical thickness and two with hippocampal volume. Multi‐omics analysis showed that certain identified miRNAs were genetically influenced and regulated genes in pathways like neurogenesis and synapse assembly.DISCUSSION: We identified miRNAs associated with cognitive domains, brain regions, and neuronal processes affected by aging and neurodegeneration, making them promising candidate blood‐based biomarkers or therapeutic targets of subclinical cognitive dysfunction.Highlights: We investigated the association of blood‐derived microRNAs with cognitive domains. Five previously identified and 14 novel microRNAs were associated with cognition. Eleven cognition‐related microRNAs were also associated with cortical thickness. Identified microRNAs were linked to genes associated with neuronal functions. Results provide putative biomarkers or therapeutic targets of cognitive aging.
- 29 August 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (10) , 7138-7159
Open AccessBlood‐derived microRNAs are related to cognitive domains in the general population
INTRODUCTION: Blood‐derived microRNAs (miRNAs) are potential candidates for detecting and preventing subclinical cognitive dysfunction. However, replication of previous findings and identification of novel miRNAs associated with cognitive domains, including their relation to brain structure and the pathways they regulate, are still lacking.METHODS: We examined blood‐derived miRNAs and miRNA co‐expression clusters in relation to cognitive domains, structural magnetic resonance imaging measures, target gene expression, and genetic variants in 2869 participants of a population‐based cohort.RESULTS: Five previously identified and 14 novel miRNAs were associated with cognitive domains. Eleven of these were also associated with cortical thickness and two with hippocampal volume. Multi‐omics analysis showed that certain identified miRNAs were genetically influenced and regulated genes in pathways like neurogenesis and synapse assembly.DISCUSSION: We identified miRNAs associated with cognitive domains, brain regions, and neuronal processes affected by aging and neurodegeneration, making them promising candidate blood‐based biomarkers or therapeutic targets of subclinical cognitive dysfunction.Highlights: We investigated the association of blood‐derived microRNAs with cognitive domains. Five previously identified and 14 novel microRNAs were associated with cognition. Eleven cognition‐related microRNAs were also associated with cortical thickness. Identified microRNAs were linked to genes associated with neuronal functions. Results provide putative biomarkers or therapeutic targets of cognitive aging.
- Open Access
Genome-Wide Association Study Meta-Analysis Uncovers Novel Genetic Variants Associated with Olfactory Dysfunction
IMPORTANCE: Olfactory dysfunction is among the earliest signs of many age-related neurodegenerative diseases and has been associated with increased mortality in older adults; however, its genetic basis remains largely unknown. OBJECTIVE: To identify the genetic loci associated with olfactory dysfunction in the general population. DESIGN, SETTING AND PARTIICIPANTS: This genome-wide association study meta-analysis (GWMA) included participants of European ancestry (N = 22,730) enrolled in four different large population-based studies, followed by a multi-ancestry GWMA including participants of African ancestry (N = 1,030). The data analysis was performed from March 2023 through June 2024. EXPOSURES: Genome-wide single nucleotide polymorphisms. MAIN OUTCOMES AND MEASURES: Olfactory dysfunction was the outcome and assessed using a 12-item smell identification test. RESULTS: GWMA revealed a novel genome-wide significant locus (tagged by rs11228623 at 11q12) associated with olfactory dysfunction. Gene-based analysis revealed a high enrichment for olfactory receptor genes in this region. Phenome-wide association studies demonstrated associations between genetic variants related to olfactory dysfunction and blood cell counts, kidney function, skeletal muscle mass, cholesterol levels and cardiovascular disease. Using individual-level data, we also confirmed and quantified the strength of these associations on a phenotypic level. Moreover, employing two-sample Mendelian Randomization analyses, we found evidence for causal associations between olfactory dysfunction and these phenotypes. CONCLUSIONS: These findings provide novel insights into the genetic architecture of the sense of smell and highlight its importance for many aspects of human health. Key Points: Question: What is the genetic basis of olfactory dysfunction, and is it causally related to adverse health outcomes? Findings: This genome-wide association study meta-analysis (GWMA) of 22,730 European and 1,030 African participants identified a novel genomic locus, enriched for olfactory receptor genes, robustly associated with olfactory dysfunction. Two-sample Mendelian Randomization analyses provided evidence for causal associations of olfactory dysfunction with biochemical, anthropometric and cardiovascular health outcomes. Meaning: These findings provide new insights into the genetic architecture of olfaction and implicate olfactory dysfunction as a causal risk factor for many aspects of human health.
Open AccessGenome-Wide Association Study Meta-Analysis Uncovers Novel Genetic Variants Associated with Olfactory Dysfunction
IMPORTANCE: Olfactory dysfunction is among the earliest signs of many age-related neurodegenerative diseases and has been associated with increased mortality in older adults; however, its genetic basis remains largely unknown. OBJECTIVE: To identify the genetic loci associated with olfactory dysfunction in the general population. DESIGN, SETTING AND PARTIICIPANTS: This genome-wide association study meta-analysis (GWMA) included participants of European ancestry (N = 22,730) enrolled in four different large population-based studies, followed by a multi-ancestry GWMA including participants of African ancestry (N = 1,030). The data analysis was performed from March 2023 through June 2024. EXPOSURES: Genome-wide single nucleotide polymorphisms. MAIN OUTCOMES AND MEASURES: Olfactory dysfunction was the outcome and assessed using a 12-item smell identification test. RESULTS: GWMA revealed a novel genome-wide significant locus (tagged by rs11228623 at 11q12) associated with olfactory dysfunction. Gene-based analysis revealed a high enrichment for olfactory receptor genes in this region. Phenome-wide association studies demonstrated associations between genetic variants related to olfactory dysfunction and blood cell counts, kidney function, skeletal muscle mass, cholesterol levels and cardiovascular disease. Using individual-level data, we also confirmed and quantified the strength of these associations on a phenotypic level. Moreover, employing two-sample Mendelian Randomization analyses, we found evidence for causal associations between olfactory dysfunction and these phenotypes. CONCLUSIONS: These findings provide novel insights into the genetic architecture of the sense of smell and highlight its importance for many aspects of human health. Key Points: Question: What is the genetic basis of olfactory dysfunction, and is it causally related to adverse health outcomes? Findings: This genome-wide association study meta-analysis (GWMA) of 22,730 European and 1,030 African participants identified a novel genomic locus, enriched for olfactory receptor genes, robustly associated with olfactory dysfunction. Two-sample Mendelian Randomization analyses provided evidence for causal associations of olfactory dysfunction with biochemical, anthropometric and cardiovascular health outcomes. Meaning: These findings provide new insights into the genetic architecture of olfaction and implicate olfactory dysfunction as a causal risk factor for many aspects of human health.
- Open Access
Circulating microRNAs are related to cognitive domains in the general population
INTRODUCTION: Circulating microRNAs have been suggested as candidates for detecting and preventing subclinical cognitive dysfunction. However, replication of previous findings and identification of novel microRNAs associated with cognitive domains, including their relation to brain structure and the pathways they regulate, are still lacking. METHODS: We examined circulating microRNAs and microRNA co-expression clusters in relation to cognitive domains, structural MRI measures, and target gene expression in 2869 participants of a population-based cohort. RESULTS: Five previously identified and 10 novel microRNAs were associated with cognitive domains. Importantly, seven of these microRNAs were also associated with cortical thickness and two with hippocampal volume. Functional genomics analysis showed that the identified microRNAs regulated genes in pathways like neurogenesis, axon guidance, and synapse assembly. DISCUSSION: We identified microRNAs associated with cognitive domains, brain regions, and neuronal processes affected by aging and neurodegeneration, making them promising candidate blood-based biomarkers or therapeutic targets of subclinical cognitive dysfunction.
Open AccessCirculating microRNAs are related to cognitive domains in the general population
INTRODUCTION: Circulating microRNAs have been suggested as candidates for detecting and preventing subclinical cognitive dysfunction. However, replication of previous findings and identification of novel microRNAs associated with cognitive domains, including their relation to brain structure and the pathways they regulate, are still lacking. METHODS: We examined circulating microRNAs and microRNA co-expression clusters in relation to cognitive domains, structural MRI measures, and target gene expression in 2869 participants of a population-based cohort. RESULTS: Five previously identified and 10 novel microRNAs were associated with cognitive domains. Importantly, seven of these microRNAs were also associated with cortical thickness and two with hippocampal volume. Functional genomics analysis showed that the identified microRNAs regulated genes in pathways like neurogenesis, axon guidance, and synapse assembly. DISCUSSION: We identified microRNAs associated with cognitive domains, brain regions, and neuronal processes affected by aging and neurodegeneration, making them promising candidate blood-based biomarkers or therapeutic targets of subclinical cognitive dysfunction.